Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Crinetics Pharmaceuticals (CRNX) Preferred Shares Issued (2017 - 2018)

Crinetics Pharmaceuticals has reported Preferred Shares Issued over the past 2 years, most recently at $9000.0 for Q4 2018.

  • Quarterly results put Preferred Shares Issued at $9000.0 for Q4 2018, down 99.92% from a year ago — trailing twelve months through Dec 2018 was $63.3 million (changed N/A YoY), and the annual figure for FY2018 was $63.3 million, up 427.29%.
  • Preferred Shares Issued for Q4 2018 was $9000.0 at Crinetics Pharmaceuticals, up from -$234000.0 in the prior quarter.
  • Over the last five years, Preferred Shares Issued for CRNX hit a ceiling of $63.5 million in Q1 2018 and a floor of -$234000.0 in Q2 2018.